|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM375890025 |
| 003 |
DE-627 |
| 005 |
20241024232246.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
240805s2024 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1080/07366205.2024.2381403
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1579.xml
|
| 035 |
|
|
|a (DE-627)NLM375890025
|
| 035 |
|
|
|a (NLM)39101584
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Lu, Huiying
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Dual-mode detection of glucose based on pistol-like DNAzyme-mediated exonuclease-assisted signal cycle
|
| 264 |
|
1 |
|c 2024
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 24.10.2024
|
| 500 |
|
|
|a Date Revised 24.10.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Detecting glucose accurately and sensitively from clinical samples like tears and saliva is still difficult. We have created a sensor that can detect glucose with high sensitivity and accuracy by combining the use of glucose oxidase (GOx) to catalyze glucose, a pistol-like DNAzyme (PLDz) to transform the signal, gold nanoparticles (AuNPs) to enhance the optical properties and the exonuclease-III (Exo-III) to amplify the signal. As a result, the proposed method exhibits a low detection limit of 7.5 pM and a wide detection range covering seven orders of magnitude. The suggested dual-mode strategy provides a sensitive, precise and specific detection method for glucose. Another advantage is that the dual-mode technique significantly improves the precision and consistency of the measurements, demonstrating its immense potential for use in biomedical research and clinical diagnostics
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a AuNPs
|
| 650 |
|
4 |
|a exonuclease-III
|
| 650 |
|
4 |
|a glucose
|
| 650 |
|
4 |
|a glucose oxidase
|
| 650 |
|
4 |
|a pistol-like DNAzyme (PLDz)
|
| 650 |
|
7 |
|a DNA, Catalytic
|2 NLM
|
| 650 |
|
7 |
|a Glucose
|2 NLM
|
| 650 |
|
7 |
|a IY9XDZ35W2
|2 NLM
|
| 650 |
|
7 |
|a Gold
|2 NLM
|
| 650 |
|
7 |
|a 7440-57-5
|2 NLM
|
| 650 |
|
7 |
|a Exodeoxyribonucleases
|2 NLM
|
| 650 |
|
7 |
|a EC 3.1.-
|2 NLM
|
| 650 |
|
7 |
|a Glucose Oxidase
|2 NLM
|
| 650 |
|
7 |
|a EC 1.1.3.4
|2 NLM
|
| 650 |
|
7 |
|a exodeoxyribonuclease III
|2 NLM
|
| 650 |
|
7 |
|a EC 3.1.11.2
|2 NLM
|
| 700 |
1 |
|
|a Wang, Xiaofeng
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t BioTechniques
|d 1988
|g 76(2024), 9 vom: 05., Seite 415-423
|w (DE-627)NLM012627046
|x 1940-9818
|7 nnns
|
| 773 |
1 |
8 |
|g volume:76
|g year:2024
|g number:9
|g day:05
|g pages:415-423
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1080/07366205.2024.2381403
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_21
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_39
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_50
|
| 912 |
|
|
|a GBV_ILN_60
|
| 912 |
|
|
|a GBV_ILN_62
|
| 912 |
|
|
|a GBV_ILN_65
|
| 912 |
|
|
|a GBV_ILN_70
|
| 912 |
|
|
|a GBV_ILN_99
|
| 912 |
|
|
|a GBV_ILN_121
|
| 912 |
|
|
|a GBV_ILN_130
|
| 912 |
|
|
|a GBV_ILN_227
|
| 912 |
|
|
|a GBV_ILN_350
|
| 912 |
|
|
|a GBV_ILN_618
|
| 912 |
|
|
|a GBV_ILN_640
|
| 912 |
|
|
|a GBV_ILN_754
|
| 912 |
|
|
|a GBV_ILN_2001
|
| 912 |
|
|
|a GBV_ILN_2002
|
| 912 |
|
|
|a GBV_ILN_2003
|
| 912 |
|
|
|a GBV_ILN_2005
|
| 912 |
|
|
|a GBV_ILN_2006
|
| 912 |
|
|
|a GBV_ILN_2007
|
| 912 |
|
|
|a GBV_ILN_2008
|
| 912 |
|
|
|a GBV_ILN_2009
|
| 912 |
|
|
|a GBV_ILN_2010
|
| 912 |
|
|
|a GBV_ILN_2012
|
| 912 |
|
|
|a GBV_ILN_2015
|
| 912 |
|
|
|a GBV_ILN_2018
|
| 912 |
|
|
|a GBV_ILN_2023
|
| 912 |
|
|
|a GBV_ILN_2035
|
| 912 |
|
|
|a GBV_ILN_2040
|
| 912 |
|
|
|a GBV_ILN_2060
|
| 912 |
|
|
|a GBV_ILN_2099
|
| 912 |
|
|
|a GBV_ILN_2105
|
| 912 |
|
|
|a GBV_ILN_2121
|
| 912 |
|
|
|a GBV_ILN_2470
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 76
|j 2024
|e 9
|b 05
|h 415-423
|